CURE vs. DBO
CURE (Direxion Daily Healthcare Bull 3x Shares) and DBO (Invesco DB Oil Fund) are both exchange-traded funds - CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%), while DBO is a Oil & Gas fund tracking the DBIQ Optimum Yield Crude Oil Index Excess Return. Both are passively managed. Over the past 10 years, CURE returned 13.35%/yr vs 12.59%/yr for DBO. Their 0.11 correlation means their historical movements had little consistent relationship. CURE charges 0.94%/yr vs 0.78%/yr for DBO.
Performance
CURE vs. DBO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE achieves a 6.99% return, which is significantly lower than DBO's 76.48% return. Over the past 10 years, CURE has outperformed DBO with an annualized return of 13.35%, while DBO has yielded a comparatively lower 12.59% annualized return.
CURE
- 1D
- -1.72%
- 1M
- -3.56%
- 6M
- 9.07%
- YTD
- 6.99%
- 1Y
- 68.66%
- 3Y*
- 7.13%
- 5Y*
- 0.86%
- 10Y*
- 13.35%
- ALL TIME*
- 24.24%
DBO
- 1D
- 1.56%
- 1M
- 24.59%
- 6M
- 53.46%
- YTD
- 76.48%
- 1Y
- 60.30%
- 3Y*
- 14.86%
- 5Y*
- 13.46%
- 10Y*
- 12.59%
- ALL TIME*
- 0.52%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $8.40M | $9.61M | $9.25M | |
| $11.01M | $10.23M | $13.95M |
CURE vs. DBO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 6.99% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
DBO Invesco DB Oil Fund | 76.48% | -11.71% | 7.85% | -4.44% | 13.04% | 60.74% | -20.99% | 28.05% | -15.22% | 4.86% |
Correlation
The correlation between CURE and DBO is -0.29, meaning they have often moved in opposite directions in the past. This relationship can weaken or reverse as market conditions change.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.29 |
Correlation (3Y) Balances recent behavior with more history. | -0.19 |
Correlation (5Y) Shows whether the relationship held over a longer period. | -0.06 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.05 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011 | 0.11 |
The correlation between CURE and DBO shifts across timeframes, from -0.29 (1 year) to 0.11 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE vs. DBO — Risk / Return Rank
CURE
DBO
CURE vs. DBO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Invesco DB Oil Fund (DBO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CURE | DBO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.12 | ||
| Sortino ratioReturn per unit of downside risk | +0.29 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.25 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | 2.31 | 2.01 | +0.31 |
| Martin ratioReturn relative to average drawdown | 5.20 | 6.09 | -0.89 |
Loading charts...
Drawdowns
CURE vs. DBO - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum DBO drawdown of -90.18%. Use the drawdown chart below to compare losses from any high point for CURE and DBO.
Loading charts...
Drawdown Indicators
| CURE | DBO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.19% | -90.18% | +20.99% |
Max Drawdown (1Y)Largest decline over 1 year | -31.10% | -27.73% | -3.37% |
Max Drawdown (3Y)Largest decline over 3 years | -51.93% | -28.20% | -23.73% |
Max Drawdown (5Y)Largest decline over 5 years | -52.23% | -37.68% | -14.55% |
Max Drawdown (10Y)Largest decline over 10 years | -69.19% | -61.69% | -7.50% |
Current DrawdownCurrent decline from peak | -15.08% | -53.56% | +38.48% |
Average DrawdownAverage peak-to-trough decline | -18.17% | -62.20% | +44.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.82% | 9.96% | +3.86% |
Volatility
CURE vs. DBO - Volatility Comparison
Direxion Daily Healthcare Bull 3x Shares (CURE) and Invesco DB Oil Fund (DBO) have volatilities of 17.62% and 17.75%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE | DBO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.62% | 17.75% | -0.13% |
Volatility (6M)Calculated over the trailing 6-month period | 35.23% | 33.77% | +1.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 46.92% | 38.53% | +8.39% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.69% | 33.35% | +11.34% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.85% | 32.20% | +17.65% |
CURE vs. DBO - Expense Ratio Comparison
CURE has a 0.94% expense ratio, which is higher than DBO's 0.78% expense ratio.
Dividends
CURE vs. DBO - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.06%, less than DBO's 1.99% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.06% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% |
DBO Invesco DB Oil Fund | 1.99% | 3.51% | 4.68% | 4.59% | 0.66% | 0.00% | 0.00% | 1.63% | 1.58% | 0.00% |
Frequently Asked Questions
CURE and DBO have a correlation of -0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DBO has higher volatility (17.75%) compared to CURE (17.62%). In terms of maximum drawdown, CURE dropped -69.19% vs DBO's -90.18%.
On 10-year performance, CURE leads with 13.35% vs 12.59% for DBO. On fees, DBO is cheaper at 0.78% per year. On volatility, CURE has been the lower-risk option at 17.62%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, CURE has performed better with a 13.35% return vs 12.59%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
DBO is cheaper with a 0.78% expense ratio, compared with 0.94% for CURE.
DBO has the higher dividend yield at 1.99%, compared with 1.06% for CURE.
CURE is categorized as Leveraged Equities, while DBO is Oil & Gas. CURE tracks Health Care Select Sector Index (300%), while DBO tracks DBIQ Optimum Yield Crude Oil Index Excess Return. They also come from different issuers: Direxion and Invesco. Their fees differ too: 0.94% for CURE and 0.78% for DBO.
CURE currently has the higher Sharpe Ratio (1.56 vs 1.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CURE and DBO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer